Therefore, either monotherapy targeting PD-1 or PD-L1, or combination treatment involving chemotherapy ... Despite the ...

Medically reviewed by Susan Russell, MD Key Takeaways Squamous cell carcinoma begins in the tissues lining the air passages in the lungs.Common symptoms include a persistent cough, shortness of breath ...

Curevac N.V. (($CVAC)) announced an update on their ongoing clinical study. Study Overview: CureVac N.V. is conducting a Phase I study titled ...

CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance maladie du ...

In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...

Hernexeos (zongertinib) received FDA accelerated approval for unresectable or metastatic non-squamous NSCLC with HER2 TKD mutations after prior treatment. The Beamion LUNG-1 trial showed a 75% ...

Identification and validation of hypoxia and energy metabolism-related gene signatures in lung adenocarcinoma and their potential implications for immunotherapy. This is an ASCO Meeting Abstract from ...